Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Birol Yıldız"'
Autor:
Emre Tekgöz, Seda Çolak, Ramazan Acar, İsmail Ertürk, Musa Barış Aykan, Birol Yıldız, Nuri Karadurmuş, Muhammet Çınar, Sedat Yılmaz
Publikováno v:
Gülhane Tıp Dergisi, Vol 64, Iss 1, Pp 103-109 (2022)
Aims:Immune-related adverse events (irAEs) may be observed due to the mechanism of action of immune checkpoint inhibitors (ICIs). This study investigated the frequency of rheumatologic irAEs and characteristics of the patients who developed rheumatol
Externí odkaz:
https://doaj.org/article/3030bca76f0e46a9b10ac20a8c0a8cb4
Autor:
Gokhan Erdem, Nuri Karadurmus, Sukru Ozaydin, Ibrahim Demirci, Bilgin Bahadir Basgoz, İsmail Ertürk, Birol Yıldız, Ramzan Ocal, Fikret Arpaci
Publikováno v:
Journal of Oncological Sciences, Vol 4, Iss 1, Pp 29-34 (2018)
Background: Lung involvement, an uncommon initial presentation of Hodgkin Lymphoma (HL), may appear as primary or secondary pulmonary HL. Although the combination of Brentuximab vedotin (BV) with AVD is suggested as an alternative treatment to combin
Externí odkaz:
https://doaj.org/article/1d537572ca9c4655b232a11086d56df5
Autor:
Musa Barış Aykan, Gül Sema Yıldıran, Nazlıcan İğret, Ramazan Acar, Birol Yıldız, İsmail Ertürk, Nuri Karadurmuş
Publikováno v:
The Bulletin of Urooncology. 21:105-109
Autor:
Birol Yıldız, Şafak Ağdeniz
Publikováno v:
Contemporary Studies of Risks in Emerging Technology, Part B ISBN: 9781804555675
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49713b3f07d6f2ee71667606af43f6c7
https://doi.org/10.1108/978-1-80455-566-820231007
https://doi.org/10.1108/978-1-80455-566-820231007
Autor:
Ramazan Acar, Semra Paydaş, Murat Yıldırım, Emrah Kılıçarslan, Ugur Sahın, Ali Dogan, DenizC Guven, Omer Ekıncı, Mesut Tıglıoglu, Isıl Erdogan, Tayfun Elıbol, Halil Kızıloz, MusaB Aykan, Selim Sayın, Kursat Kaptan, Ender Soydan, Ayla Gokmen, Ramazan Esen, Ibrahim Barısta, Murat Albayrak, Ismail Erturk, Birol Yıldız, GulsemaY Keskın, Meltem Aylı, Nuri Karadurmus
Publikováno v:
Journal of Cancer Research and Therapeutics. 19:138
Autor:
Aykan, Musa Barış, Yıldıran, Gül Sema, İğret, Nazlıcan, Acar, Ramazan, Ertürk, Birol Yıldız,İsmail, Karadurmuş, Nuri
Publikováno v:
Üroonkoloji Bülteni; Sep2022, Vol. 21 Issue 3, p105-109, 5p
Publikováno v:
Volume: 5, Issue: 2 141-166
Eskişehir Osmangazi Üniversitesi Sosyal Bilimler Dergisi
Eskişehir Osmangazi Üniversitesi Sosyal Bilimler Dergisi
Bütçeleme bir işletmenin etkin ve etkili yönetimi açısından vazgeçilmez bir yönetim aracıdır. Ancak geleneksel yaklaşımla hazırlanan bütçelerde iki temel sorun bulunmaktadır. Birincisi geleneksel bütçeler gerçeği yansıtmayacak k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=tubitakulakb::d0e70a9c7cc3652e8247daf34b4a473f
https://dergipark.org.tr/tr/pub/ogusbd/issue/10985/131473
https://dergipark.org.tr/tr/pub/ogusbd/issue/10985/131473
Autor:
Birol Yildiz, Ismail Erturk, Galip Buyukturan, Bilgin Bahadir Basgoz, Ramazan Acar, Kenan Saglam
Publikováno v:
Medicine Science, Vol 9, Iss 1, Pp 45-8 (2020)
Diabetes mellitus is a metabolic disorder with an increasing incidence all over the world leading to high sequelae and high mortality rates behind other microvascular and macrovascular complications. The deterioration in angiogenesis in particular is
Externí odkaz:
https://doaj.org/article/1a23bc28558b4c5c8e12c7fc43d95957
Autor:
Birol Yildiz, Ismail Erturk, Nuri Karadurmus, Zeki Gokhan Surmeli, Ece Esin, Sukru Ozaydinli, Bilgin Bahadir Basgoz, Fikret Arpaci
Publikováno v:
Journal of Oncological Sciences, Vol 4, Iss 2, Pp 70-73 (2018)
Aim: Even though ABO blood group surface antigens are expressed in red blood cells, they can be observed in many normal and pathologic cells. Relationship between ABO blood groups and progression and prognosis of cancer has been mainly demonstrated i
Externí odkaz:
https://doaj.org/article/f6a1186e9c2948338cb9d6f1755429ec